CD4 and colitis: We subsequently examined the anti-inflammatory effects of NEt-3IB in an experimental colitis model induced by transferring CD4+CD45RBhigh T cells into C.B-17-scid/scid mice and treating with chow containing 0.015% NEt-3IB (approximately 30 mg/kg/day) or with regular chow as a control.